Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An intranasal lentiviral booster reinforces the waning mRNA vaccine-induced SARS-CoV-2 immunity that it targets to lung mucosa
Benjamin Vesin, Jodie Lopez, Amandine Noirat, et al.
Molecular Therapy (2022) Vol. 30, Iss. 9, pp. 2984-2997
Open Access | Times Cited: 22

Showing 22 citing articles:

Live-attenuated vaccine sCPD9 elicits superior mucosal and systemic immunity to SARS-CoV-2 variants in hamsters
Geraldine Nouailles, Julia M. Adler, Peter Pennitz, et al.
Nature Microbiology (2023) Vol. 8, Iss. 5, pp. 860-874
Open Access | Times Cited: 60
Promises and challenges of mucosal COVID-19 vaccines
Abhay P. S. Rathore, Ashley L. St. John
Vaccine (2023) Vol. 41, Iss. 27, pp. 4042-4049
Open Access | Times Cited: 18
Intramuscular mRNA BNT162b2 vaccine against SARS-CoV-2 induces neutralizing salivary IgA
Miri Stolovich-Rain, Sujata Kumari, Ahuva Friedman, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 14
Lentiviral Vectors as a Vaccine Platform against Infectious Diseases
Kirill Nemirov, Maryline Bourgine, François Anna, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 846-846
Open Access | Times Cited: 13
Harnessing T-Cells for Enhanced Vaccine Development against Viral Infections
Zhen Zhuang, Jianfen Zhuo, Yaochang Yuan, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 478-478
Open Access | Times Cited: 3
Development of T cell antigen-based human coronavirus vaccines against nAb-escaping SARS-CoV-2 variants
Hao Zhou, Ping Leng, Yang Wang, et al.
Science Bulletin (2024) Vol. 69, Iss. 15, pp. 2456-2470
Closed Access | Times Cited: 2
Intranasal VLP-RBD vaccine adjuvanted with BECC470 confers immunity against Delta SARS-CoV-2 challenge in K18-hACE2-mice
Katherine S. Lee, Nathaniel A. Rader, Olivia A. Miller-Stump, et al.
Vaccine (2023) Vol. 41, Iss. 34, pp. 5003-5017
Open Access | Times Cited: 7
A lentiviral vector encoding fusion of light invariant chain and mycobacterial antigens induces protective CD4+ T cell immunity
Jodie Lopez, François Anna, Pierre Authié, et al.
Cell Reports (2022) Vol. 40, Iss. 4, pp. 111142-111142
Open Access | Times Cited: 11
Full eradication of pre‐clinical human papilloma virus‐induced tumors by a lentiviral vaccine
Laëtitia Douguet, Ingrid Fert, Jodie Lopez, et al.
EMBO Molecular Medicine (2023) Vol. 15, Iss. 10
Open Access | Times Cited: 5
Genetic therapies in cystic fibrosis
Jennifer L. Taylor‐Cousar, A. Christopher Boyd, Eric W.F.W. Alton, et al.
Current Opinion in Pulmonary Medicine (2023) Vol. 29, Iss. 6, pp. 615-620
Closed Access | Times Cited: 5
Durable CD8 T Cell Memory against SARS-CoV-2 by Prime/Boost and Multi-Dose Vaccination: Considerations on Inter-Dose Time Intervals
Ambra Natalini, Sonia Simonetti, Carmel Sher, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 14367-14367
Open Access | Times Cited: 9
Comparison of preclinical efficacy of immunotherapies against HPV-induced cancers
Anastasia Demidova, Laëtitia Douguet, Ingrid Fert, et al.
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 674-687
Open Access | Times Cited: 1
Broad-spectrum vaccine via combined immunization routes triggers potent immunity to SARS-CoV-2 and its variants
Man Xing, Yihan Wang, Xinyu Wang, et al.
Journal of Virology (2023) Vol. 97, Iss. 10
Open Access | Times Cited: 4
A conserved N protein nano‐vaccine of COVID‐19 exerts potent and cross‐reactive humoral and cellular immune responses in mice
Bing Li, Jing Zhang, Yang Huang, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 9
Closed Access | Times Cited: 2
mRNA cancer vaccines from bench to bedside: a new era in cancer immunotherapy
Alireza Shariati, Pouria Khani, Farzad Nasri, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access
A live attenuated vaccine confers superior mucosal and systemic immunity to SARS-CoV-2 variants
Geraldine Nouailles, Julia M. Adler, Peter Pennitz, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 3
Intranasal VLP-RBD vaccine adjuvanted with BECC470 confers immunity against Delta SARS-CoV-2 challenge in K18-hACE2-mice
Katherine S. Lee, Nathaniel A. Rader, Olivia A. Miller, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
A Novel Piggyback Strategy for mRNA Delivery Exploiting Adenovirus Entry Biology
Myungeun Lee, Paul Boucher, Logan Thrasher Collins, et al.
(2022)
Open Access | Times Cited: 2
A Novel Piggyback Strategy for mRNA Delivery Exploiting Adenovirus Entry Biology
Myungeun Lee, Paul Boucher, Logan Thrasher Collins, et al.
Viruses (2022) Vol. 14, Iss. 10, pp. 2169-2169
Open Access | Times Cited: 2
Full-Lung Prophylaxis against SARS-CoV-2 by One-Shot or Booster Intranasal Lentiviral Vaccination in Syrian Golden Hamsters
Benjamin Vesin, Pierre Authié, Catherine Blanc, et al.
Vaccines (2022) Vol. 11, Iss. 1, pp. 12-12
Open Access | Times Cited: 1
Mice humanized for MHC and hACE2 with high permissiveness to SARS-CoV-2 omicron replication
Fabien Le Chevalier, Pierre Authié, Sébastien Chardenoux, et al.
Microbes and Infection (2023) Vol. 25, Iss. 7, pp. 105142-105142
Open Access
Mice Humanized for Major Histocompatibility Complex and Angiotensin-Converting Enzyme 2 with High Permissiveness to SARS-CoV-2 Omicron Replication
Fabien Le Chevalier, Pierre Authié, Sébastien Chardenoux, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Closed Access
Page 1

Scroll to top